HARMONY OUTCOMES

Definition

Tested albiglutide for cardiovascular outcomes in an enrolled group of 9,463 people who had type 2 diabetes alongside existing cardiovascular disease (Hernandez et al., Lancet 2018). MACE came down 22%. GSK had withdrawn albiglutide from global markets a year before those results reached print, and the decision was commercial rather than clinical.

HARMONY OUTCOMES trial deep-dive →

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.

Other terms under trial

• SURMOUNT-5
• SURMOUNT-2
• SURMOUNT-3
• SURPASS-2
• SUSTAIN-6
• REWIND
• PIONEER 6
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• SCALE Diabetes
• STEP 2
• SUMMIT
• SCALE Maintenance

Where the evidence lives

• HARMONY OUTCOMES trial deep-dive
• The full GLP-1 glossary (149 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers